IGI Laboratories to Hold Conference Call for 2nd Quarter 2013 Results
July 17 2013 - 12:20PM
Business Wire
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based
topical generic drug development and manufacturing company,
announced the Company will hold a conference call at 4:30 pm ET on
Thursday, July 25, 2013 to discuss 2nd quarter 2013 results.
The Company invites you to listen to the call by dialing
1-866-515-2909. International participants should call
1-617-399-5123. The passcode for the conference call is
19569314.
This call is being webcast by Thomson and can be accessed at
IGI's website at www.igilabs.com.
The webcast is also being distributed through the Thomson
StreetEvents Network. Individual investors can listen to the call
at www.earnings.com, Thomson's individual investor portal, powered
by StreetEvents (www.streetevents.com), a password-protected event
management site.
About IGI Laboratories, Inc.
IGI Laboratories is a developer and manufacturer of topical
formulations for the pharmaceutical, OTC, and cosmetic markets. Our
mission is to be a leading player in the generic topical
prescription drug market.
IGI Laboratories, Inc.Jenniffer Collins,
856-697-1441www.igilabs.com
Teligent (NASDAQ:TLGT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teligent (NASDAQ:TLGT)
Historical Stock Chart
From Apr 2023 to Apr 2024